Výsledky vyhledávání - "Niki Y M, Au"

Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine

Autor: Benjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, Niki Y M Au, Karl C K Chan, John K C Li, Lison W C Fung, Leo L H Luk, Leo C H Tsang, Dennis K M Ip, Leo L M Poon, Gabriel M Leung, J S Malik Peiris, Nancy H L Leung

Publikováno v: The Journal of Infectious Diseases. 227:251-255

We administered BNT162b2 as a third dose to 314 adults aged ≥30 years who had previously received 2 doses of inactivated vaccine. We collected blood samples before the third dose and again after 1 month and 6 months, and found robust antibody respo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96ba5b0046a1e8e490e0bcb869941996
https://doi.org/10.1093/infdis/jiac380

Zobrazit plný text záznamu

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

Autor: Nancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, Niki Y M Au, Yvonne Y Ng, Leo L H Luk, Karl C K Chan, John K C Li, Yonna W Y Leung, Leo C H Tsang, Sara Chaothai, Kelvin K H Kwan, Dennis K M Ip, Leo L M Poon, Gabriel M Leung, J S Malik Peiris, Benjamin J Cowling

Publikováno v: Clinical Infectious Diseases. 76:e299-e307

Background Limited data exist on antibody responses to mixed vaccination strategies that involve inactivated coronavirus disease 2019 (COVID-19) vaccines, particularly in the context of emerging variants. Methods We conducted an open-label trial of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::52930cde3dc79c643f8185d8ebad0120
https://doi.org/10.1093/cid/ciac458

Zobrazit plný text záznamu

Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)

BackgroundThere are few trials comparing homologous and heterologous third doses of COVID-19 vaccination with inactivated vaccines and mRNA vaccines.MethodsWe conducted an open-label randomized trial in adults >=18 years of age who received two doses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cb3eaba37341c85d2e8e0ba7b3b4fe4
https://doi.org/10.1101/2022.08.25.22279158

Zobrazit plný text záznamu

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine

Autor: Benjamin J, Cowling, Samuel M S, Cheng, Mario, Martín-Sánchez, Niki Y M, Au, Karl C K, Chan, John K C, Li, Lison W C, Fung, Leo L H, Luk, Leo C H, Tsang, Dennis K M, Ip, Leo L M, Poon, Gabriel M, Leung, J S Malik, Peiris, Nancy H L, Leung

Publikováno v: The Journal of infectious diseases.

We administered BNT162b2 as a third dose to 314 adults aged ≥30 years who had previously received two doses of inactivated vaccination. We collected blood samples before the third dose and again after one month and six months, and found robust anti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0411de776036772caa2f9dd5c098a9d2
https://pubmed.ncbi.nlm.nih.gov/36108092

Zobrazit plný text záznamu

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine

Autor: Benjamin J. Cowling, Samuel M. S. Cheng, Mario Martín-Sánchez, Niki Y. M. Au, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Dennis K. M. Ip, Leo L. M. Poon, Gabriel M. Leung, J. S. Malik Peiris, Nancy H. L. Leung

IntroductionThird doses of COVID-19 vaccination provide an important boost to immunity, reducing the risk of symptomatic infection and the risk of severe disease. Third doses have been particularly important for improving protection against variants.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8e0fad7ecc25459efc28aba8a1a5fbc
https://doi.org/10.1101/2022.07.18.22277741

Zobrazit plný text záznamu

Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2Omicron variant in adults who received two doses of inactivated vaccine

Autor: Nancy H L, Leung, Samuel M S, Cheng, Mario, Martín-Sánchez, Niki Y M, Au, Yvonne Y, Ng, Leo L H, Luk, Karl C K, Chan, John K C, Li, Yonna W Y, Leung, Leo C H, Tsang, Sara, Chaothai, Kelvin K H, Kwan, Dennis K M, Ip, Leo L M, Poon, Gabriel M, Leung, J S, Malik Peiris, Benjamin J, Cowling

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Limited data exist on antibody responses to mixed vaccination strategies involving inactivated COVID-19 vaccines, particularly in the context of emerging variants.We conducted an open label trial of a third vaccine dose of an mRNA vaccine (BNT162b2,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1a311f55371be724e72c78e516a56855
https://pubmed.ncbi.nlm.nih.gov/35675370

Zobrazit plný text záznamu

Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine

Autor: Nancy H. L. Leung, Samuel M. S. Cheng, Mario Martín-Sánchez, Niki Y. M. Au, Yvonne Y. Ng, Leo L. H. Luk, Karl C. K. Chan, John K. C. Li, Yonna W. Y. Leung, Leo C. H. Tsang, Sara Chaothai, Kelvin K. H. Kwan, Dennis K. M. Ip, Leo L. M. Poon, Gabriel M. Leung, J. S. Malik Peiris, Benjamin J. Cowling

BackgroundLimited data exist on antibody responses to mixed vaccination strategies involving inactivated COVID-19 vaccines, particularly in the context of emerging variants.MethodsWe conducted an open label trial of a third vaccine dose of an mRNA va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d657ce1048b1ef6b1c0ab2bba5c05c7
https://doi.org/10.1101/2022.01.20.22269586

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání